Through innovation, research, education and clinical excellence Curaleaf International is shining a light on the possibilities of cannabis and leading the global cannabis industry towards a bright future of superior products and widespread acceptance.
Curaleaf International continues to expand access to innovative medical cannabis solutions worldwide with the international rollout of the Que Medical Inhalation Device (QMID).
The Que Medical Inhalation Device (QMID), developed to meet EU medical-service standards, is the world’s first CE-Certified medical cannabis liquid inhaler delivering precision, consistency, and discretion for patients.
Every unit has passed the safety, performance and biocompatibility tests in line with European Pharmacopoeia. This patient-friendly, compact, and discreet device is designed with precision in mind, giving prescribers confidence in this controlled delivery system.
